Table 2.
System affected | Symptoms and signs | Reference |
---|---|---|
Motor | ||
Action tremor | [1,3] | |
Cerebellar gait ataxia | [1,3] | |
Parkinsonism | [1,3] | |
Reflex myoclonus | [11] | |
Cognitive | ||
Executive dysfunction | [12] | |
Dementia | [13] | |
Autonomic | ||
Urinary dysfunction | [3] | |
Erectile dysfunction | [3] | |
Constipation/fecal incontinence | [12] | |
Orthostatic hypotension | [14] | |
Psychiatric | ||
Depression | [15-17] | |
Anxiety | [15,17] | |
Irritability, agitation, apathy | [16] | |
Other CNS, medical | ||
Impaired olfaction | [8] | |
Hearing loss | [8] | |
Hypertension | [18,19] | |
Sleep apnea | [20] | |
Peripheral nervous system | ||
Length dependent neuropathy | [3] | |
Non-length dependent sensory neuropathy | [4,8,21-28] | |
Femalesa | ||
Muscle pain/fibromyalgia | [19,29] | |
Hypothyroidism | [19] | |
Radiography | ||
MRI T2 hyperintensities in the middle cerebellar peduncles (MCP sign) or brainstem | [4,30] | |
MRI T2 hyperintensities in the splenium of the corpus callosum | [31] | |
MRI white matter lesions in the cerebrum | [4,30] | |
Moderate to severe generalized atrophy | [4,30] | |
Corpus callosum atrophy | [4] | |
Cerebellar atrophy | [4] |
aAdditional signs that are typical findings in females, much more so than males. CNS, central nervous system; MRI, magnetic resonance imaging.